Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PIOGLITAZONE HYDROCHLORIDE
- Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude
- Effects of Pioglitazone in Calcific Aortic Valve Disease
- Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
- Semaglutide in Nonalcoholic Fatty Liver Disease
- The Role of Pioglitazone in Vascular Transcriptional Remodeling
- Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
- A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
- Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
- The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
- Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
- Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
- Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
- Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver
- Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.
- Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
- Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
- Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
- A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
- Quantifying Hepatic Mitochondrial Fluxes in Humans
- Efficacy and Safety of Dapagliflozin in Patients With Non-alcoholic Steatohepatitis
- Effects of Pioglitazone on Stress Reactivity and Alcohol Craving
- Pioglitazone and Insulin Resistance in ADT
- Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
- Pioglitazone Therapy Targeting Fatigue in Breast Cancer
- Insulin Resistance and Androgen Deprivation Therapy
- Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver
- A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
- Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
- Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention
- Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.
- Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model
- Drug Interaction Study of MGL-3196 With Pioglitazone
- Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose
- Insulin Resistance Following ADT for Prostate CA
- Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
- Effect of Pioglitazone on T2DM Patients With COVID-19
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
- Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)
- Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases
- GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study
- Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
- Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke
- Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss
- Pioglitazone for Idiopathic Gastroparesis
- Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
- Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke
- Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome
- To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
- Dapagliflozin Plus Pioglitazone in T1DM
- Insulin Regulation of Lipolysis and Lipolysis Proteins
- Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy
- Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)
- Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease
- Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
- Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
- A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
- Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Non-alcoholic Fatty Liver Disease in Type 2 Diabetic Patients With Fatty Liver
- The Effect of Esomeprazole on Type 2 Diabetes
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary Syndrome
- A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy
- Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
- Insulin Signaling in Skeletal Muscle
- Study of Pioglitazone in Sporadic Inclusion Body Myositis
- CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
- Study of NGM313 in Obese Participants
- Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
- Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes
- Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- Pioglitazone Therapy for Chronic Granulomatous Disease
- A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)
- Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
- Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
- Brown Fat Activation Study
- Second STOP After Pioglitazone Priming in CML Patients
- Pioglityazone and Imatinib for CML Patients
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- HbA1c Variability in Type II Diabetes
- Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone
- Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
- Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
- PPARγ Agonist Treatment for Cocaine Dependence
- Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
- Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)
- An Extension Study of PEAK Trial
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
- Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
- Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
- Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
- Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
- Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
- Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia
- Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
- The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
- A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
- Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI
- Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Incretin-based Drugs and the Risk of Heart Failure
- A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers
- Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
- Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers
- Fatty Liver Study in Patients With Type II Diabetes
- Preventing Squamous Cell Skin Cancer
- Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination
- Ovulation Induction in Clomiphene Citrate Resistant PCO Women
- Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
- The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients
- Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
- Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal Muscle
- Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
- Trial for People With Established Type 2 Diabetes During Ramadan
- A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD
- AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease
- Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers
- A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease
- Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
- The Practical Evidence of Antidiabetic Combination Therapy in Korea
- Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
- Neuroprotection of Pioglitazone in Acute Ischemic Stroke
- Obesity, Sleep Apnea, and Insulin Resistance
- Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects
- Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers
- Pioglitazone Tablets Specified Drug-use Survey
- Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers
- Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
- Glycemic Durability After Metformin Failure
- A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
- Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.
- Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
- Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
- Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"
- Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients
- Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus
- Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"
- Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
- Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
- Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
- Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
- Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
- Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
- Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"
- Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
- Liraglutide Hospital Discharge Trial
- Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
- Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
- Triple Therapy in Type 2 Diabetic Patients
- A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
- Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes
- A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants
- A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
- Pioglitazone Decreases Visceral Fat Metabolism
- Mediators of Abnormal Reproductive Function in Obesity (MARO)
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions
- The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fasting Conditions
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
- Pioglitazone for the Treatment of Bipolar Depression
- A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes
- Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis
- Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients
- Pioglitazone in Thyroid Cancers
- Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
- Role of Proinflammatory Signaling in Alcohol Craving
- Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma
- Metabolic Abnormalities in HIV-infected Persons
- Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients
- Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects
- Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)
- Phielix et al.: Hepatic Fat Content and Adipokines
- Pioglitazone in Patients With Mood Disorders
- Pioglitazone to Treat Opioid Withdrawal Symptoms
- A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
- Effects of Pioglitazone in Hypertensive Patients
- Effects of Different Early Intensive Therapies on Long-term β-cell Function
- Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
- Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)
- Pioglitazone and Metformin in Diabetic Children
- Pioglitazone for Heroin and for Nicotine Dependence
- Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone
- Changes in Bone Turnover With Increased Incretin Hormone Exposure
- Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock
- Glucose Control in Pre-Diabetic Renal Transplant Patients
- Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
- The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
- Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)
- Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
- Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
- Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects
- Effect of Adipokines in Hemodialysis Patients
- Insulin Resistance in Non-alcoholic Fatty Liver Disease
- Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
- A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
- Pioglitazone in Early Parkinson's Disease
- Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
- Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients
- Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD
- A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus
- A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients
- Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
- A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)
- Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
- Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
- Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
- Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)
- Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea
- Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
- Endometriosis: Immunomodulation
- 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Week
- Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
- Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
- Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study
- Study the Relationship Between Obesity and Hepatitis C Replication
- Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes
- Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
- Pharmacogenomics of Thiazolidinediones
- Pioglitazone in Psoriasis- A Clinical and Molecular Study.
- Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes
- Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)
- Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
- Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
- The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
- Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
- Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients
- A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
- Renal and Hormonal Effects of Pioglitazone
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
- A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects
- A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers
- INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
- The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis
- A Study in Participants With Type 2 Diabetes Mellitus
- Fracture Risk With Thiazolidinediones
- Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin
- A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment
- Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
- A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
- 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
- Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin
- HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
- Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial
- Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- DPP-4 Inhibition and TZD for DM Prevention
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
- An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
- Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
- University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
- A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
- Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes
- Pioglitazone in Alzheimer Disease
- Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
- Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins
- Pioglitazone for Oral Premalignant Lesions
- Effect of Thiazolidinediones on Human Bone
- Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance
- Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba
- The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome
- Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects
- Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
- Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
- A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
- Pathophysiology of Uric Acid Nephrolithiasis
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
- Thiazolidinedione Intervention With Vitamin D Evaluation
- Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
- Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
- Effects of Pioglitazone on Platelet Function
- Pioglitazone on Pancreatic Steatosis and Bone Health
- Safety and Efficacy of Albiglutide in Type 2 Diabetes
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
- Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
- Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage
- Insulin Resistance in Pulmonary Arterial Hypertension
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
- Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
- Molecular Mechanisms of Type 2 Diabetes Mellitus
- Pioglitazone Versus Metformin in Type 2 Diabetes
- Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
- Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
- Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)
- Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality
- Response To Oral Agents in Diabetes (ROAD)- Pilot Study
- Pioglitazone for Lung Cancer Chemoprevention
- Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
- Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
- Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.
- Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
- Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
- Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
- Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
- Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.
- Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.
- Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
- Inflammation and Insulin Resistance in Rheumatoid Arthritis
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus
- A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator
- Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
- How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?
- Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
- Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
- Androgen Deprivation Therapy Study
- Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
- Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
- Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
- Bone Turnover in Type 2 Diabetes Patients
- Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
- Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
- Anti-Inflammatory Effects of Pioglitazone
- MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
- Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
- Effect of Pioglitazone on Inflammation in Cystic Fibrosis
- Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
- Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
- Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis
- Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin
- Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
- Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
- Pioglitazone Incretin Study
- Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
- Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
- Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg
- Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
- Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
- Exercise and Pioglitazone for HIV-Metabolic Syndromes
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
- Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
- A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
- Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
- Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma
- Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy
- Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
- Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function
- Mechanisms Underlying Metabolic Syndrome in Obesity
- Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin
- Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes
- Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus
- Effect of Thiazolidinedione Treatment Vascular Risk Markers
- Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
- PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
- Dyslipidemia in Type 2 Diabetes (0767-034)
- Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
- Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
- MK0767 in Type 2 Diabetes (0767-012)
- A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
- MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
- Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
- Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure
- Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
- Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
- Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
- Influence of Pioglitazone for Renal Transplant Function in Diabetics
- Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
- Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
- The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers
- Safety Study of Pioglitazone Compared To Glyburide on Liver Function
- Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)
- Study of Rivoglitazone in Type 2 Diabetes Mellitus
- Comparison Between Pioglitazone and SES With type2 DM
- Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
- Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
- The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
- Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.
- Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
- Pioglitazone to Treat Fatty Liver in People With HIV Infection
- Medication in Early Diabetes (MED) Study
- Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
- Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
- Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer
- Ketosis Prone Diabetes in African-Americans
- Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
- Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
- Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity
- Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
- "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
- Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
- Initial Combination With Pioglitazone Study (0431-064)
- Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
- Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
- "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
- Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
- Pioglitazone and Losartan Provides Additional Renoprotection
- Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
- A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
- Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
- Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
- Effect of Pioglitazone on Ambulatory Blood Pressure
- A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
- Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease
- Optimizing Body Composition for Function in Older Adults
- The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
- Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
- Pioglitazone in Impaired Glucose Tolerance
- Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
- A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
- Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917
- Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
- Integrating the Genetic and Metabolic Faces of Obesity
- GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
- Role of Pioglitazone in Preventing Diabetes
- Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
- A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
- Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
- Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
- Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
- Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
- ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
- Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
- GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
- Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus
- Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.
- Actos Now for Prevention of Diabetes (ACT NOW)
- GALLANT 6 Tesaglitazar vs. Pioglitazone
- Islet Transplantation in Type 1 Diabetic Patients
- Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
- Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)
- Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
- Study In People With Type 2 Diabetes
- Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
- Pioglitazone in Hepatitis C
- Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes
- Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin
- Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
- Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
- ARREST PAD (Peripheral Arterial Disease)
- Effects of Pioglitazone in Congenital Adrenal Hyperplasia
- Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
- Pioglitazone Treatment in Polycystic Ovary Syndrome
- Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
- Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone
- Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance
- Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
- Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
- Insulin Resistance Intervention After Stroke Trial
- Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
- Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
- Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
- Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
- Treating Nonalcoholic Steatohepatitis With Pioglitazone
- A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)
- Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Clinical trials list
click for details